Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine the efficacy and safety of a new long-acting beta-agonist
for asthma patients (GSK159797) following dosing for 14 days.